Schuler Jack W's Form 4 filing
Accelerate Diagnostics, Inc (AXDX) · filed Aug 10, 2022
- Accession no.
- 0001104659-22-088722
- Filed
- Aug 10, 2022
- Trade date
- Aug 9, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuler Jack WCIK 0001021412 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 | Common Stock | PPurchaseAcquired | +307,256 | –F7 | – | – | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F7
The $9,500,000 aggregate principal amount of Notes (face value) were acquired by the reporting person in exchange for the forgiveness of a loan in the amount of approximately $6,352,972 (including interest) owed to the reporting person.
Referenced by the price of 1 transaction in Table II.